Clinical Trial Update: Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant. [Phase 2]

View source ↗

Summary

Preliminary Phase 2 study evaluating Dornase Alfa for chest infections after lung transplant completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Lung Transplant Infection

Drugs mentioned

• Dornase alfa (dornase alfa)

Snippet

Sponsor: The Alfred | Conditions: Lung Transplant Infection, Lower Respiratory Tract Infection | Phase 2 | Status: COMPLETED | Results posted: 2019-08-28